32 天前 - … The increased T-cell activation from ICIs promotes enhanced anti-tumor activity
and induces immune-related adverse events (irAEs) [8]. These unique treatment-specific …

33 天前 - … patients treated with immune checkpoint inhibitors, H. pylori infection was associated
with shorter immune-related … , modulate immune cell functions, and inhibit the colonization …

33 天前 - … ) occurring during immunotherapy in patients with cancer and … immune-related
adverse events (irAEs). We enrolled 20 cancer patients who received PD-1 checkpoint inhibitors …

33 天前 - … The use of ICIs is associated with a class of side effects known as immune-related
adverse events (irAEs) across all tumor types. The frequency of these reactions varies based …

33 天前 - … 20 months after receiving PD-1 monoclonal antibody treatment and had no previous
… immune-related adverse events associated with lung cancer immune checkpoint inhibitors, …

34 天前 - … Immune-related hepatotoxicity occurs in approximately 6·8% of patients treated with
immune checkpoint inhibitors … cautiously consider immune-related adverse events as one …

34 天前 - … patients, they can also 72 cause some adverse reactions, namely immune-related
adverse … VigiBase, this study collected adverse reaction reports of tumor patients who used …

34 天前 - … Immune checkpoint inhibitors (ICIs) have dramatically improved the prognosis of …
cancer patients, but they have also introduced a new issue of immune-related adverse events (…

34 天前 - … Immune checkpoint inhibitors (ICIs) represent a cornerstone in contemporary cancer
… , yet managing immune-related adverse events (irAEs) remains pivotal. These events, …

34 天前 - … Immune-related adverse events (irAEs) are complications of the use of immune
checkpoint inhibitors (ICIs). ICI-associated gastritis is one of the main irAEs. The gastric …